Kadant: can replacement parts outlast acquisition-driven growth?
Correction
Not assessable
Outcome updated
17 November KAI historical vendor price comparison; supersedes only the earlier note's timing explanation, not the forecast
- What we originally said
MarketBeat recorded $286.89 one minute earlier, 15:59 EST; that was not the close [K9].
- What actually happened
Correction: For 17 November 2026, Stock Analysis lists a $286.79 close; MarketBeat's daily table labels $286.89 its closing price. The cited records do not establish a 15:59 EST trade or explain the $0.10 difference. We withdraw the one-minute-earlier explanation, including its repetition in the earlier correction.
- What we learned
We retain $286.79 as the attributed Stock Analysis historical tracking mark. Neither figure is an executable quote or an actual entry. The operating thesis and six review dates are unchanged.
- What remains uncertain
The original MarketBeat page capture is unavailable, and the reason for the vendors' $0.10 difference is not established. The price data do not establish a purchase or realized return.
- What we will check next
Recover the original timestamped source receipt or a comparable independent historical market record before asserting a cause for the difference.
- Why we changed this note
The cited MarketBeat daily table labels $286.89 as its closing price, and the cited records do not substantiate the stated 15:59 observation.
- Supporting evidence
- Kadant historical price dataEvent · Checked Primary source · Public accessEvidence limits Rolling page; publication date unknown.
- Kadant price historyEvent · Checked Independent evidence · Public accessEvidence limits Rolling page; current table labels the amount closing price and does not provide a 15:59 timestamp.
Review overdue · no later published assessment recorded · Planned
Source repair ·
Source repair
Source repair
Update published
This repairs a source reference. It does not establish a new outcome.
K7 and K9 source-date labels, not the original forecast or price observations
- What we originally said
MarketBeat recorded $286.89 one minute earlier, 15:59 EST; that was not the close [K9].
- What actually happened
Correction: the 17 November dates displayed as publication dates for the Stock Analysis and MarketBeat pages are the dates of the price observations, not verified publication dates of those rolling webpages.
- What we learned
The $286.79 historical close and $286.89 earlier observation remain dated market observations, not executable prices or evidence of a trade.
- What remains uncertain
The original publication dates of those rolling webpages are not established.
- What we will check next
A precision-aware citation field or independently datelined record would permit the underlying metadata to be corrected.
- Supporting evidence
- Kadant historical price dataEvent · Checked Primary source · Public accessEvidence limits Rolling page; its original webpage publication date is unknown.
- Kadant price chartEvent · Checked Independent evidence · Public accessEvidence limits Rolling page; chart observation time is not a webpage publication date.
Explore this signal
Long Term at a glance
Short reader summary
Kadant sold $218.4 million of parts and consumables in a quarter. How much came from customers returning to service existing machines? The filings do not say. Organic orders, margins and cash after investment offer a way to test that idea as acquired growth rolls off.
Exact asset or item
Kadant Inc. common shares (NYSE: KAI), United States, USD
Asset type
Listed investment
Reference price
286.79
Currency code
USD
Price observed at
2026-11-17T16:00:00-05:00
What this number represents
Tracking price
What remains unproven
Kadant Inc. common shares, NYSE: KAI, USD. Historical share-price observation: $286.79 at the regular US session close on 17 Nov 2026 at 16:00 EST (18 Nov 05:00 SGT), a vendor-recorded NYSE-listed close [K7]. MarketBeat recorded $286.89 one minute earlier, 15:59 EST; that was not the close [K9]. Neither observation is a current offer, actual purchase or claim of fair value. A broker’s executable price, account eligibility and all-in FX and dealing costs were not verified.
Exact asset or item
Exact asset or item
Kadant Inc. common shares (NYSE: KAI), United States, USD
Asset type
Listed investment
Ticker
KAI
Exchange
NYSE
How to identify this exact asset
Imagine a paper mill that has already bought an expensive machine. When a working part wears out, the mill has a reason to buy a replacement even if it does not buy another machine. Kadant supplies capital equipment along with replacement parts and consumables. Its installed base can therefore support recurring demand. But a part is not a subscription: factories can cut shifts, delay maintenance purchases, change suppliers or negotiate prices [K2].
Price and what it means
Entry or reference price
286.79
Currency code
USD
Price observed at
2026-11-17T16:00:00-05:00
What this number represents
Tracking price
Price evidence status
Indicative
Price source
Publisher: Stock Analysis
published date precision: day
Source publication date 2026-11-17
Matching price source ID
K7
Purchase, sale and realised profit
No purchase, sale, executable entry or realized return was established.
The developments we connected
Separate development
What changed
Q2: reported and organic bookings diverged
Date of the development
Evidence status
Observed
What the evidence shows
In Q2 bookings rose 16% overall but fell 1% organically; acquisitions and currency added to reported growth [K3].
Source IDs
- K3
What changed
Q3: organic bookings improved
Date of the development
Evidence status
Observed
What the evidence shows
Kadant disclosed Q3 results on 3 Nov at 16:39 EST (21:39 UTC). On 10 Nov it filed the quarter’s 10-Q. These are earlier disclosures newly examined in this 19 Nov source, not a fresh earnings announcement today. Q3 bookings rose 22% year over year to $291.1m; management calculated 10% organic bookings growth, with acquisitions adding 12 percentage points. Revenue rose 15% to $313.2m, with 4% organic growth. Bookings divided by revenue was about 0.93. Orders and revenue relate to different cohorts; this ratio neither establishes cancellations nor predicts the next quarter’s cash [K1,K2].
Source IDs
- K1
- K2
Emerging insight
The question for a shareholder is whether older machines keep earning enough from wear parts AFTER acquired growth no longer boosts year-on-year comparisons. A move in the group’s quoted shares cannot answer that question.
How this exact asset could benefit
Original thesis: Kadant’s installed machinery may generate durable replacement-part demand as acquired businesses roll into comparable results. A sustained gain requires organic orders and repeatedly positive cash after capital spending without persistent margin erosion; reported growth alone is not evidence.
Who could benefit
Who
Kadant common shareholders
How they could benefit
Additional parts earnings must survive operating costs, capital needs, taxes, financing and dilution before owners benefit. The share price paid also matters.
Evidence status
Still unproven
What we observed
In the quarter ended 3 October, its parts and consumables generated $218.4m of revenue versus $188.4m the prior year [K2]. That is group-wide revenue, not an audited measure of repeat purchases by the same customers. On 30 April Kadant acquired Böhler Profil, which makes specialty profiles including material used for industrial knives. Its newly consolidated sales and orders can increase reported growth even if older businesses gain little. Both buyer and seller report the transaction; they do not establish contract-level proceeds from replacement parts [K2,K5,K6].
Kadant disclosed Q3 results on 3 Nov at 16:39 EST (21:39 UTC). On 10 Nov it filed the quarter’s 10-Q. These are earlier disclosures newly examined in this 19 Nov source, not a fresh earnings announcement today. Q3 bookings rose 22% year over year to $291.1m; management calculated 10% organic bookings growth, with acquisitions adding 12 percentage points. Revenue rose 15% to $313.2m, with 4% organic growth. Bookings divided by revenue was about 0.93. Orders and revenue relate to different cohorts; this ratio neither establishes cancellations nor predicts the next quarter’s cash [K1,K2].
In Q2 bookings rose 16% overall but fell 1% organically; acquisitions and currency added to reported growth [K3]. The contrast makes Q3’s organic improvement worth tracking, not proven durable. Q3 gross margin slipped from 45.2% to 44.7%. Operating cash flow was $62.9m versus $47.3m; Kadant’s non-GAAP free cash flow was $58.1m versus $44.1m. Neither can be attributed to recent orders or the Austrian business from these disclosures [K1]. In fiscal 2025 adjusted EBITDA fell to $216.3m from $229.7m, a warning against extrapolating the record quarter [K4].
What remains unproven
Original public news comes from issuer/SEC and seller; neither an earnings release nor a macro indicator supplies independent evidence that a particular customer reordered. Source recheck: 19 Nov 2026 SGT. Undisclosed: named repeated purchaser cohort, segment-level cash, live broker ticket and investor fees.
| Bookings growth, year over year | Q2 2026 | Q3 2026 |
|---|---|---|
| Reported | +16% | +22% |
| Organic | −1% | +10% |
- Kadant Q3 2026 · 2026-11-03
- Kadant Q2 2026 · 2026-08-04
What to check before acting
Entry conditions
Kadant Inc. common shares, NYSE: KAI, USD. Historical share-price observation: $286.79 at the regular US session close on 17 Nov 2026 at 16:00 EST (18 Nov 05:00 SGT), a vendor-recorded NYSE-listed close [K7]. MarketBeat recorded $286.89 one minute earlier, 15:59 EST; that was not the close [K9]. Neither observation is a current offer, actual purchase or claim of fair value. A broker’s executable price, account eligibility and all-in FX and dealing costs were not verified.
Possible upside
Repeated profitable replacement demand could support cash available to owners, if organic growth persists after acquisition comparisons normalize.
Possible downside
The buyer recorded a $170.2m net acquisition price [K2]. To benefit owners, any additional parts earnings must survive freight, labor, inventory financing, investment and taxes. A full order book coupled with weak cash, shrinking margins, or acquisitions funded with costly debt could leave shareholders worse off. Broad US manufacturing output rose 0.3% in October, but was down 0.1% excluding motor vehicles and parts. Neither national measure tells us how an individual Kadant customer ran its machines [K8].
Price or return range method
Illustration only: ten shares at the historical mark imply $2,867.90 before costs. At a hypothetical $5 fee to buy and $5 to sell, break-even would be $287.79 per share before spreads, taxes, dividends or FX. The assumed fees are not an actual broker quote. Selling below a quoted mark, exchange-rate changes or paying too high a valuation can defeat a sound business thesis.
Costs and fees
Illustration only: ten shares at the historical mark imply $2,867.90 before costs. At a hypothetical $5 fee to buy and $5 to sell, break-even would be $287.79 per share before spreads, taxes, dividends or FX. The assumed fees are not an actual broker quote. Selling below a quoted mark, exchange-rate changes or paying too high a valuation can defeat a sound business thesis.
How hard it may be to sell
NYSE listing provides a trading venue, not a guaranteed fill at the historical close. No executable broker price or account eligibility was verified.
Key risks
Action now: track bookings, organic growth, parts revenue, gross margin and cash after capex on the same reporting calendar. Record acquisition anniversaries. Upside needs repeated profitable demand, not a single record. Downside includes cheaper alternative parts, factory downtime, lumpy capital-equipment awards, leverage and dilution; price risk remains even if operating cash improves.
What an ordinary reader can do next
Action now: track bookings, organic growth, parts revenue, gross margin and cash after capex on the same reporting calendar. Record acquisition anniversaries. Upside needs repeated profitable demand, not a single record. Downside includes cheaper alternative parts, factory downtime, lumpy capital-equipment awards, leverage and dilution; price risk remains even if operating cash improves.
- OrdersSeparate organic demand from acquisitions and currency
- CashCompare operating cash after capital spending and margins
- Owner outcomeCheck leverage, dilution and entry costs separately
- Kadant Q3 2026 · 2026-11-03
Original forecast record
Original forecast in full
Will yesterday’s machines bring tomorrow’s orders?
Kadant Inc. common shares, NYSE: KAI, USD. Historical share-price observation: $286.79 at the regular US session close on 17 Nov 2026 at 16:00 EST (18 Nov 05:00 SGT), a vendor-recorded NYSE-listed close [K7]. MarketBeat recorded $286.89 one minute earlier, 15:59 EST; that was not the close [K9]. Neither observation is a current offer, actual purchase or claim of fair value. A broker’s executable price, account eligibility and all-in FX and dealing costs were not verified.
Imagine a paper mill that has already bought an expensive machine. When a working part wears out, the mill has a reason to buy a replacement even if it does not buy another machine. Kadant supplies capital equipment along with replacement parts and consumables. Its installed base can therefore support recurring demand. But a part is not a subscription: factories can cut shifts, delay maintenance purchases, change suppliers or negotiate prices [K2].
In the quarter ended 3 October, its parts and consumables generated $218.4m of revenue versus $188.4m the prior year [K2]. That is group-wide revenue, not an audited measure of repeat purchases by the same customers. On 30 April Kadant acquired Böhler Profil, which makes specialty profiles including material used for industrial knives. Its newly consolidated sales and orders can increase reported growth even if older businesses gain little. Both buyer and seller report the transaction; they do not establish contract-level proceeds from replacement parts [K2,K5,K6].
The question for a shareholder is whether older machines keep earning enough from wear parts AFTER acquired growth no longer boosts year-on-year comparisons. A move in the group’s quoted shares cannot answer that question.
Three numbers that cannot be substituted
Kadant disclosed Q3 results on 3 Nov at 16:39 EST (21:39 UTC). On 10 Nov it filed the quarter’s 10-Q. These are earlier disclosures newly examined in this 19 Nov source, not a fresh earnings announcement today. Q3 bookings rose 22% year over year to $291.1m; management calculated 10% organic bookings growth, with acquisitions adding 12 percentage points. Revenue rose 15% to $313.2m, with 4% organic growth. Bookings divided by revenue was about 0.93. Orders and revenue relate to different cohorts; this ratio neither establishes cancellations nor predicts the next quarter’s cash [K1,K2].
In Q2 bookings rose 16% overall but fell 1% organically; acquisitions and currency added to reported growth [K3]. The contrast makes Q3’s organic improvement worth tracking, not proven durable. Q3 gross margin slipped from 45.2% to 44.7%. Operating cash flow was $62.9m versus $47.3m; Kadant’s non-GAAP free cash flow was $58.1m versus $44.1m. Neither can be attributed to recent orders or the Austrian business from these disclosures [K1]. In fiscal 2025 adjusted EBITDA fell to $216.3m from $229.7m, a warning against extrapolating the record quarter [K4].
The buyer recorded a $170.2m net acquisition price [K2]. To benefit owners, any additional parts earnings must survive freight, labor, inventory financing, investment and taxes. A full order book coupled with weak cash, shrinking margins, or acquisitions funded with costly debt could leave shareholders worse off. Broad US manufacturing output rose 0.3% in October, but was down 0.1% excluding motor vehicles and parts. Neither national measure tells us how an individual Kadant customer ran its machines [K8].
Illustration only: ten shares at the historical mark imply $2,867.90 before costs. At a hypothetical $5 fee to buy and $5 to sell, break-even would be $287.79 per share before spreads, taxes, dividends or FX. The assumed fees are not an actual broker quote. Selling below a quoted mark, exchange-rate changes or paying too high a valuation can defeat a sound business thesis.
Six dated tests
Original thesis: Kadant’s installed machinery may generate durable replacement-part demand as acquired businesses roll into comparable results. A sustained gain requires organic orders and repeatedly positive cash after capital spending without persistent margin erosion; reported growth alone is not evidence.
6 MONTHS · 19 May 2027. Compare the next two available quarterly booking, revenue and organic-growth disclosures with their own prior-year periods. Separate acquired growth and exchange effects. Check whether orders lag sales in successive periods rather than declaring failure from one ratio.
1 YEAR · 19 Nov 2027. After the Böhler acquisition anniversary, compare parts/consumables with capital-equipment growth where reported. An increase from a larger consolidated base is not proof of replacement sales to existing customers. If cohort data remain undisclosed, say so.
2 YEARS · 19 Nov 2028. Main test: assess two full-year records of organic demand, gross margin, operating cash and cash after actual capital spending. If sales rise but margins and cash persistently weaken, the proposed replacement-parts advantage is contradicted. If parts-level cash is not disclosed, do not assign group cash to that segment.
3 YEARS · 19 Nov 2029. Compare cumulative available cash and leverage/diluted shares with acquisition and financing costs. Keep the $170.2m transaction separate from subsequent deals; if incremental returns are not disclosed, cannot conclude it paid for itself.
4 YEARS · 19 Nov 2030. Compare replacement demand with equipment demand across a documented industrial slowdown; keep pricing and mix distinct from units if disclosed. Without such a period or disaggregated data, resilience remains untested.
5 YEARS · 19 Nov 2031. Judge repeat cash per diluted share across observed periods separately from total shareholder return. Include actual costs and dividends only when documented. No trade means no realized return.
Action now: track bookings, organic growth, parts revenue, gross margin and cash after capex on the same reporting calendar. Record acquisition anniversaries. Upside needs repeated profitable demand, not a single record. Downside includes cheaper alternative parts, factory downtime, lumpy capital-equipment awards, leverage and dilution; price risk remains even if operating cash improves.
Original forecast date and time
2026-11-19T01:17:06+08:00
View chart values
| Quarter | Revenue |
|---|---|
| Q3 2025 | 188.4 |
| Q3 2026 | 218.4 |
- Kadant Q3 10-Q · 2026-11-10
Forecasts and review dates
6 months
Review date
2027-05-19
Original forecast
6 MONTHS · 19 May 2027. Compare the next two available quarterly booking, revenue and organic-growth disclosures with their own prior-year periods. Separate acquired growth and exchange effects. Check whether orders lag sales in successive periods rather than declaring failure from one ratio.
What to measure
Bookings and revenue versus prior year; organic versus acquired growth and FX.
What must happen
Organic orders hold up beyond a single quarter.
What would challenge the forecast
Orders repeatedly lag sales while organic demand weakens.
Current outcome
Not yet due
1 year
Review date
2027-11-19
Original forecast
1 YEAR · 19 Nov 2027. After the Böhler acquisition anniversary, compare parts/consumables with capital-equipment growth where reported. An increase from a larger consolidated base is not proof of replacement sales to existing customers. If cohort data remain undisclosed, say so.
What to measure
Parts versus equipment growth after the acquisition anniversary.
What must happen
Comparable evidence separates replacement demand from acquired sales.
What would challenge the forecast
Acquisition-driven sales alone leave repeat demand unproven.
Current outcome
Not yet due
2 years
Review date
2028-11-19
Original forecast
2 YEARS · 19 Nov 2028. Main test: assess two full-year records of organic demand, gross margin, operating cash and cash after actual capital spending. If sales rise but margins and cash persistently weaken, the proposed replacement-parts advantage is contradicted. If parts-level cash is not disclosed, do not assign group cash to that segment.
What to measure
Two full years of organic demand, gross margin, operating cash and capital spending.
What must happen
Organic demand and positive cash after capex persist without sustained margin erosion.
What would challenge the forecast
Rising sales alongside persistently weaker margins and cash contradict the thesis.
Current outcome
Not yet due
3 years
Review date
2029-11-19
Original forecast
3 YEARS · 19 Nov 2029. Compare cumulative available cash and leverage/diluted shares with acquisition and financing costs. Keep the $170.2m transaction separate from subsequent deals; if incremental returns are not disclosed, cannot conclude it paid for itself.
What to measure
Cumulative cash, leverage, financing costs and diluted shares.
What must happen
Cash gains survive acquisition and financing costs per diluted share.
What would challenge the forecast
Absent incremental returns, acquisition payback cannot be concluded.
Current outcome
Not yet due
4 years
Review date
2030-11-19
Original forecast
4 YEARS · 19 Nov 2030. Compare replacement demand with equipment demand across a documented industrial slowdown; keep pricing and mix distinct from units if disclosed. Without such a period or disaggregated data, resilience remains untested.
What to measure
Replacement demand versus equipment demand in a documented slowdown.
What must happen
Comparable evidence shows resilient replacement demand during the slowdown.
What would challenge the forecast
No disaggregation or slowdown leaves resilience untested.
Current outcome
Not yet due
5 years
Review date
2031-11-19
Original forecast
5 YEARS · 19 Nov 2031. Judge repeat cash per diluted share across observed periods separately from total shareholder return. Include actual costs and dividends only when documented. No trade means no realized return.
What to measure
Cash per diluted share and separately documented shareholder return.
What must happen
Cash generation recurs on a diluted-share basis.
What would challenge the forecast
Dilution or weaker repeat cash erodes the operating case; no trade means no realized return.
Current outcome
Not yet due
Sources
Dated source
Source ID
K1
Source link and publication date
K1 | 3 Nov 2026, 16:39 EST | Issuer Q3 release, reported/organic bridge and non-GAAP reconciliation.
Publisher: Kadant
published date precision: day
Source publication date 2026-11-03
What this source supports
3 Nov 2026, 16:39 EST | Issuer Q3 release, reported/organic bridge and non-GAAP reconciliation.
Source ID
K2
Source link and publication date
Publisher: Kadant / SEC EDGAR
published date precision: day
Source publication date 2026-11-10
What this source supports
Filed 10 Nov 2026 | SEC 10-Q for quarter ended 3 Oct: product revenues, demand, seasonality, transaction and risks. Company-authored.
Source ID
K3
Source link and publication date
Publisher: Kadant
published date precision: day
Source publication date 2026-08-04
What this source supports
4 Aug 2026, 16:37 EDT | Issuer Q2 release: 16% total bookings growth vs 1% organic decline; currency and acquisitions included in reported comparison.
Source ID
K4
Source link and publication date
Publisher: Kadant
published date precision: day
Source publication date 2026-02-18
What this source supports
18 Feb 2026, 17:03 EST | Fiscal-year 2025 and Q4 results | Company’s earlier full-year comparison, adjusted EBITDA is not cash.
Source ID
K5
Source link and publication date
Publisher: voestalpine
published date precision: day
Source publication date 2026-11-11
What this source supports
Seller H1 FY2026/27, transaction effective 30 Apr 2026 | Seller consolidation note, not evidence of subsequent buyer receipts.
Source ID
K6
Source link and publication date
Publisher: voestalpine
published date precision: day
Source publication date 2026-11-11
What this source supports
Seller H1 FY2026/27 | Seller describes the Bruckbach specialty-profile operation. Same seller as K5, not a third independent confirmation.
Source ID
K7
Source link and publication date
Publisher: Stock Analysis
published date precision: day
Source publication date 2026-11-17
What this source supports
17 Nov 2026 NY regular close | Market-data row: USD open 285.35, high 292.13, low 283.97, close 286.79. Event/research time distinct.
Source ID
K8
Source link and publication date
K8 | 17 Nov 2026, 09:15 EST | Federal Reserve G.17: October industrial production release.
Publisher: Federal Reserve Board
published date precision: day
Source publication date 2026-11-17
What this source supports
17 Nov 2026 | Federal Reserve G.17: US industrial production for October, context not Kadant’s demand. See the dated 17 November 2026 entry in the Board’s release archive.
Source ID
K9
Source link and publication date
Publisher: MarketBeat
published date precision: day
Source publication date 2026-11-17
What this source supports
17 Nov 2026, 15:59 EST | MarketBeat intraday chart: $286.89, a minute before the regular close, not a conflicting simultaneous trade.
Source limits
Original public news comes from issuer/SEC and seller; neither an earnings release nor a macro indicator supplies independent evidence that a particular customer reordered. Source recheck: 19 Nov 2026 SGT. Undisclosed: named repeated purchaser cohort, segment-level cash, live broker ticket and investor fees.
AI powered research